Quantum-Si, Inc. (QSI)
0.7983
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 11:11
Quantum-Si Debt to Equity Ratio : 0.0181 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0181 |
| March 31, 2026 | 0.0185 |
| December 31, 2025 | 0.0189 |
| September 30, 2025 | 0.0196 |
| June 30, 2025 | 0.0504 |
| March 31, 2025 | 0.0488 |
| December 31, 2024 | 0.0601 |
| September 30, 2024 | 0.0657 |
| June 30, 2024 | 0.0071 |
| March 31, 2024 | 0.0571 |
| December 31, 2023 | 0.0563 |
| September 30, 2023 | 0.0529 |
| June 30, 2023 | 0.0514 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.0493 |
| December 31, 2022 | 0.0486 |
| September 30, 2022 | 0.044 |
| June 30, 2022 | 0.0416 |
| March 31, 2022 | 0.037 |
| December 31, 2021 | 0.0169 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.0485 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 1.042 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Champions Oncology, Inc. | 1.167 |
| Medpace Holdings, Inc. | 0.3322 |
| Avantor, Inc. | 0.6568 |
| Personalis, Inc. | 0.1616 |
| Adaptive Biotechnologies Corp. | 2.872 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 193.58M |
| Total Liabilities (Quarterly) | 13.37M |
| Shareholders Equity (Quarterly) | 180.20M |
| Current Ratio | 9.969 |
| Net Debt Paydown Yield | 0.91% |